MedicaidPrior AuthMedium impact
Pedmark® (sodium thiosulfate injection) (Revised)
Humana·LA · Oncology, Pediatrics·Medicaid
Effective date
Jan 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Louisiana Medicaid now requires prior authorization for Pedmark (sodium thiosulfate injection) used to prevent hearing loss in pediatric cancer patients receiving cisplatin chemotherapy. Coverage requires the patient to be 1 month to 18 years old with localized, non-metastatic solid tumors receiving cisplatin therapy.
Action Required
Before January 1, 2026: Billing team must establish prior authorization workflow for Pedmark (sodium thiosulfate injection) for Louisiana Medicaid patients. Verify patients meet all three criteria: age 1 month to 18 years, localized non-metastatic solid tumor, and receiving cisplatin therapy. Visit www.humana.com/PAL for specific medical and procedural coding information. Claims will be denied without proper prior authorization.